David J. Cummins
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Alzheimer's disease research and treatments, Analytical Chemistry and Chromatography, Dementia and Cognitive Impairment Research, Statistical Methods and Inference
Most-Cited Works
- → Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease(2001)1,292 cited
- → Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition(1997)831 cited
- → Brain to Plasma Amyloid-β Efflux: a Measure of Brain Amyloid Burden in a Mouse Model of Alzheimer's Disease(2002)565 cited
- → Apolipoprotein E is essential for amyloid deposition in theAPPV717Ftransgenic mouse model of Alzheimer's disease(1999)485 cited
- → Neuroinflammation‐induced acceleration of amyloid deposition in the APPV717F transgenic mouse(2001)116 cited
- → Iteratively reweighted partial least squares: A performance analysis by monte carlo simulation(1995)113 cited
- → Molecular Diversity in Chemical Databases: Comparison of Medicinal Chemistry Knowledge Bases and Databases of Commercially Available Compounds(1996)112 cited
- → DoMCoSAR: A Novel Approach for Establishing the Docking Mode That Is Consistent with the Structure−Activity Relationship. Application to HIV-1 Protease Inhibitors and VEGF Receptor Tyrosine Kinase Inhibitors(2000)75 cited
- → Confidence Intervals for Nonparametric Curve Estimates(2001)65 cited
- → Integrating Everything: The Molecule Selection Toolkit, a System for Compound Prioritization in Drug Discovery(2016)50 cited